Andrews University

Digital Commons @ Andrews University
Faculty Publications

Physical Therapy

2014

A randomized clinical trial on the effects of
extracorporeal shockwave therapy, joint
mobilizations and exercise on plantar heel pain in
patients with plantar fasciitis.
Elizabeth Oakley
Andrews University, oakleye@andrews.edu

Paolo Sanzo
Lakehead University

Follow this and additional works at: http://digitalcommons.andrews.edu/pt-pubs
Part of the Physical Therapy Commons
Recommended Citation
Oakley, Elizabeth and Sanzo, Paolo, "A randomized clinical trial on the effects of extracorporeal shockwave therapy, joint mobilizations
and exercise on plantar heel pain in patients with plantar fasciitis." (2014). Faculty Publications. Paper 5.
http://digitalcommons.andrews.edu/pt-pubs/5

This Article is brought to you for free and open access by the Physical Therapy at Digital Commons @ Andrews University. It has been accepted for
inclusion in Faculty Publications by an authorized administrator of Digital Commons @ Andrews University. For more information, please contact
repository@andrews.edu.

International Journal of Sports Science 2014, 4(1): 27-37
DOI: 10.5923/j.sports.20140401.05

A Randomized Clinical Trial on the Effects of
Extracorporeal Shockwave Therapy, Joint Mobilizations
and Exercise on Plantar Heel Pain in Patients with
Plantar Fasciitis
Paolo Sanzo1,*, Elizabeth Oakley2
1
School of Kinesiology, Lakehead University, Thunder Bay, P7B 5E1, Canada
Department of Physical Therapy, Andrews University, Berrien Springs, 49104, United States of America

2

Abstract Plantar fasciitis (PF) is the most common cause of heel pain today impacting on the patient’s walking ability,
work tolerance, and ability to participate in active sport. Two million people in the United States (US) are treated for PF
yearly with heel pain accounting for 11 to 15% of visits to medical professionals. It is estimated that 10% of the US
population will develop PF during their lifetime. Treatment for PF may include a variety of interventions ranging from
conservative treatment to surgical interventions. One of the suggested treatments for PF is the use of extracorporeal
shockwave therapy (ECSWT). ECSWT is a relatively new therapeutic modality that has been used in the treatment of PF and
a variety of other musculoskeletal disorders with some success reported. Normally healthcare providers do not treat with the
use of only one modality or treatment approach but rather a combination of treatments in an attempt to obtain a desired
positive effect on the patient. The research available on the use of ECSWT is limited in that it has not been determined
whether this modality used in isolation, or in combination is the most effective. Research has been conducted comparing
ECSWT to placebo and a variety of controls but the effectiveness of combinations of treatment has not been studied.
Therefore, the purpose of this study was to compare the effects of ECSWT alone, to ECSWT and joint mobilization, and
ECSWT and exercise, on heel pain in patients with PF, as measured by the visual analog scale (VAS) and Lower Extremity
Functional Scale (LEFS). Subjects (N=75) were randomly assigned into 3 groups: ECSWT, ECSWT and joint mobilizations
to the talocrural, subtalar, and first metatarsophalangeal (MTP) joint, or ECSWT and stretching for the gastrocnemius, soleus,
and plantar fascia and strengthening for the ankle. Subjects received three treatments in total spaced one week apart. A VAS
for pain and LEFS were measured pre-treatment and three months post-treatment. All groups demonstrated statistically
significant improvement over time in all VAS scores and in the LEFS (P<.05). There was a statistically significant difference
in VAS for heel pain following activity between the ECSWT and joint mobilization group and ECSWT and exercise group
(F= 3.577, p= .033) with a greater reduction in pain in the ECSWT and joint mobilization group. Further research is required
using an alternative study design to compare the combinations of treatment to a control or placebo group. The findings of this
study, however, indicate that if ECSWT is going to be combined with another treatment, then the combination of ECSWT and
joint mobilization may be more effective than combining ECSWT with exercise.
Keywords Extracorporeal shockwave therapy, Plantar fasciitis, Joint mobilizations, Exercise

1. Introduction
Plantar fasciitis (PF) is the most common cause of heel
pain today with 10% of the population in the United States
(US) developing it in their lifetime[11, 20, 43]. The
functional implications of this disorder result in decreased
walking tolerance, the inability to complete daily functional
* Corresponding author:
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and work related tasks and the inability to participate in
active exercise and sport. Two million people are treated for
PF in the US yearly with heel pain accounting for 11 to 15%
of visits to medical professionals (physicians,
physiotherapists, chiropractors and athletic therapists)[11, 20,
43]. Although the exact causes of PF are unknown, it is felt
that PF may be associated with several factors including
overuse, poor intrinsic muscle strength, over pronation and
various foot deformities[7, 10, 27, 48]. Other risk factors
also include increased age, increased body mass index (BMI)
greater than 30kg/m2, increased height and weight, decreased
ankle dorsiflexion and decreased first metatarsophalangeal
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(MTP) joint range of motion (ROM)[29, 53, 56, 58].
Questions regarding whether PF is an inflammatory
condition with prostaglandin mediated inflammation, or
rather a degenerative condition have arisen and may impact
on treatment decisions[23]. PF often does not respond to
typical treatments that are used for acute inflammatory
conditions and this may be partly due to the lack of
inflammatory mediators present. Typical treatments for PF
include interventions ranging from conservative to surgical.
The use of non-steroidal anti-inflammatory medications
(NSAIDS), therapeutic modalities such as ultrasound
therapy, laser and interferential current, orthotics, nights
splints and a variety of taping techniques have been proposed
with mixed results reported[33]. Short term relief has been
reported with the combination of NSAIDS delivered via
iontophoresis or with the use of custom or pre-fabricated
orthotics or night splints[33, 61]. Other proposed treatments
include the use of manual therapy and stretching and
strengthening exercises[3, 9, 12, 15, 23, 26, 30, 33, 36, 44, 45,
59]. Stretching exercises for the gastrocnemius, soleus and
plantar fascia have been shown to provide short term pain
relief lasting only a few hours to a few days[18, 31, 39, 40,
47, 49]. It has been recommended that the calf muscle
stretches should be held for 30 second holds and performed
for 3-5 repetitions per day[18, 40, 49]. Longer relief has been
reported in patients treated with fascial specific stretching
exercises[13, 16, 52]. Stretching and mobilizations of the
first MTP into dorsiflexion as well, may be beneficial[14].
There has been limited, high quality studies performed on the
use of manual therapy as an intervention for PF. Suggested
mobilizations to the talocrural, subtalar and first MTP joints
have been recommended but the evidence to support the use
of manual therapy to these articulations is contradictory[33,
34, 60]. Some studies have reported that combinations of
treatment may be the optimal treatment choice for patients
with PF. For example, combining manual therapy with
exercise may be more effective than combining
electrotherapeutic modalities and exercise[9].
Drake et al[16] examined the effects of stretching
compared to custom foot orthotics in 15 patients with PF.
Stretches consisted of plantar fascial, gastrocnemius and
soleus stretches and general ROM exercises first thing in the
morning. Significant improvement was demonstrated with
both the use of orthotics and stretching[16]. Renan Ordine et
al[40] also examined the effect of myofascial trigger point
therapy versus stretching exercises on patients with plantar
heel pain. Sixty patients were randomly assigned to either the
stretching group or the stretching and manual therapy group.
Self-stretching exercises consisted of gastrocnemius, soleus
and plantar fascial stretches while the manual therapy group
consisted of trigger point pressure and longitudinal stroking
over the gastrocnemius muscle. Clinically significant
improvement was evident with the combination of stretching
and manual soft tissue techniques[40].
Extracorporeal shockwave therapy (ECSWT) is a new
therapeutic modality that has been used in the treatment of
acute and chronic PF and a variety of other musculoskeletal

conditions with varied success reported[5, 6, 50]. The exact
physiological affect and mechanism on healing is unknown
but several hypotheses exist. A shockwave unit generates
soundwaves at a frequency of 10-15 Hz causing cavitation
bubbles and a water jet effect which creates microscopic
holes and hemorrhaging in the plantar fascia. This initiates a
local inflammatory reaction and chemical changes[41].
These physiological effects have been proposed to be
beneficial in the treatment of the chronic and degenerative
changes present in the tissue of the plantar fascia[7, 21].
Other hypotheses on the affects of ECSWT include the
degeneration of axons and sensory nerves, the activation of
the Gate Control Theory, the chemical alteration of receptor
neurotransmitters and cell mediums and reduced production
of inflammatory mediators, calcitonin gene related peptide
and substance P[21, 22, 32, 37, 46]. Once again, these
proposed benefits may help reduce pain and initiate healing
in the plantar fascia.
Studies examining the effectiveness of ECSWT in patients
with PF have reported positive treatment effects in
decreasing pain and improving function with success ranging
from 50 to 90% with a low recurrence rate of 5 to 7%[14, 29].
A systematic review and meta-analysis on the effectiveness
of ECSWT in the treatment of plantar heel pain, however,
has reported mixed findings and the studies that did find
positive results had a small effect size[54].
Gollwitzer et al[21] examined the effects of ECSWT on
40 patients with PF. Patients were randomly assigned to
either the ECSWT group or the sham group. The ECSWT
treatment protocol consisted of three sessions of 2000
electromagnetic generated shockwaves spaced one week
apart. A visual analog scale (VAS) was used to compare the
effects of the treatments. Significant improvement was noted
in the ECSWT group as compared to the sham treatment
group[21]. Gerdesmeyer et al[20] also examined the effects
of radially generated ECSWT versus placebo in a very large
study with 245 patients with chronic PF. Clinically
significant improvement in the VAS scores and in the
functional scale scores was evident in the ECSWT group
compared to the placebo group. Overall success rate was
61% compared to 42% in the placebo group[20].
In another large retrospective study of 225 patients with
chronic PF who were treated with ECSWT, Chuckpaiwong
et al[7] reported success rates of 71% at three months post
treatment and 77% at twelve months post treatment. Similar
positive findings were reported in Cheing’s study comparing
ECSWT and ultrasound therapy on plantar heel pain as
measured with the VAS and functional tolerances for
standing and walking[6]. Several authors have summarized
the use of ECSWT in the treatment of PF and have described
the common use of the VAS in combination with other
functional measures to analyse the effects of the treatment.
Common parameters used in the treatment protocols cited
was 2000 shockwaves applied to the painful region and
treated three times per week, spaced one week apart[6, 12].
Wang et al[55] examined the long term effects of ECSWT
on 168 patients with chronic PF compared to patients having
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NSAIDS, orthotics, physical therapy and exercise using a
100 point scoring system for pain and a VAS. The ECSWT
group demonstrated excellent results in 69.1% of the cases
compared to 0% in the control group. Malay et al[32]
examined the effects of ECSWT on 172 patients compared to
a placebo group with a single treatment. VAS scores were
significantly improved in the shockwave group in
comparison to the placebo group at three months and 12
months post treatment. Rompe et al[44] compared the effects
of plantar fascial specific stretching to ECSWT on 102
patients with PF. They reported that patients that received
plantar fascial specific stretching demonstrated significant
improvement in acute pain and symptoms when compared to
the ECSWT group alone. Looney et al[31] compared the
combined effects of a home stretching program for the calf
muscles and plantar fascia and the use of soft tissue
mobilization using a Graston Instrument on the numerical
pain rating scale, Lower Extremity Functional Scale (LEFS)
and Global Rating of Change Scale in 10 patients with PF.
All patients demonstrated a significant improvement at the
eight week follow up with the combined treatment
interventions[37].

physiotherapy clinic. Eighty-five patients diagnosed with PF
were referred by their physician into the study. The primary
investigator, a registered physiotherapist, screened each
patient for inclusion and exclusion criteria. Three
participants did not meet the inclusion criteria and seven did
not consent to participate in the study.
All participants were between the ages of 22 and 68 years.
All participants met the following inclusion criteria: (1) had
unilateral foot pain localized to the heel, anteromedial
calcaneal tubercle, body of the fascia or medial arch; (2) had
heel pain in the morning with the first few steps and; (3) had
heel pain after getting up after prolonged sitting, walking or
running. Participants were excluded from the study if they
met the following exclusion criteria: (1) had previous
surgery to the plantar fascia; (2) had any other form of
treatment during the study period excluding the intervention
assigned; (3) had a history of foot fracture or congenital
deformity of the foot; (4) used an assistive device such as an
ankle foot orthoses; (5) had bilateral heel pain; (6) had any
contraindications such as vascular or neurological disorders
of the feet, pregnancy, implanted metal, or were taking
NSAIDS, aspirin or coumadin.

1.1. Clinical Justification and Purpose

2.2. Outcome Measures

The use of ECSWT continues to expand clinically. As
highlighted previously, several studies have examined the
effects of ECSWT in isolation for PF, or in comparison to
placebo and sham treatments, but rarely in combination with
other treatments. Healthcare providers (physiotherapists,
athletic therapists, chiropractors) normally do not treat with
only one modality or treatment approach but rather a
combination of treatments. Therefore, the purpose of this
study was to assess the effects of ECSWT in isolation
compared to ECSWT combined with either joint
mobilizations or exercise on plantar heel pain in patients
with PF as measured by the VAS and LEFS. It was
hypothesized that ECSWT combined with either exercise or
joint mobilizations would have a more positive effect on
function and heel pain than ECSWT alone as measured by
the LEFS and VAS.

The primary outcome measure commonly used in studies
examining the effectiveness of various treatments for PF
include the VAS and the LEFS[6, 7, 8, 9, 20, 21, 31, 32, 55].
Thus, the intensity of heel pain at rest, after activity, and
overall improvement in heel pain, were assessed using a 100
mm horizontal linear VAS. The self-report VAS has
evidence of good validity, reliability and psychometric
properties, and has been validated as a reliable measure for
pain in musculoskeletal disorders[25, 51]. The pooled
coefficients for the VAS ranges from .73-.80 for test-retest
reliability and the pooled value for construct validity
from .82-.94[25, 51]. The minimally clinically significant
difference for the VAS score is a change of 30 millimeters on
a 100 millimeter VAS[25, 51]. Pain, however, is a complex,
subjective and multi-dimensional sensation. As highlighted
previously, this dependent variable is commonly used in the
analysis of pain but we must also consider the practical
difficulties of its use. This outcome measure must be
administered electronically or on paper; when using paper
scales it must be insured that the length of the line is in fact
not distorted in length by copying or printing; and lastly, the
orientation of the scale (horizontal versus vertical) may
produce varied results among different users[28, 57]. As a
result, a horizontal VAS scale was used in the current study
and we insured that no distortion was present and that the
scale was in fact 100 mm in length. Subjects filled out the
VAS and were asked to consider the following questions: (1)
their level of heel pain at rest; (2) their level of heel pain
following activity and; (3) how much better their heel pain
was at that time compared to the initial onset. The amount of
pain was estimated by measuring in millimeters the distance
from the “no pain” marker to the mark provided by the

2. Methods
2.1. Subjects
This randomized clinical trial pre-test post-test design
included 75 subjects divided into three treatment groups. The
treatment groups consisted of either ECSWT, ECSWT and
joint mobilizations to the talocrural, subtalar, and first MTP
joint, or ECSWT and stretching exercises for the
gastrocnemius, soleus and plantar fascia and strengthening
for the ankle. Prior to recruiting subjects, ethical approval for
the study was obtained by the university Research Ethics
Board.
The sample of convenience was recruited over a one year
period of time from an urban, private, outpatient
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subject.
Secondary outcomes in this study included overall
functional abilities. Functional ability was assessed using the
LEFS. The LEFS has evidence of good psychometric
properties, validity and reliability. The LEFS has an internal
consistency ranging from α = .90-.96, test–retest reliability
ranging from .88-.94, and minimal detectable change and
minimally clinical significant differences of nine[4, 8, 58].
The LEFS is useful with either acute or chronic impairment,
is sensitive to change over time, and can be used in subjects
of all ages and functional levels[4, 8, 58].
2.3. Data Collection and Test Procedures
The principal investigator, who was a student completing
this study in partial fulfillment of his doctoral degree,
obtained voluntary consent from subjects, assessed, and
randomly assigned each subject to a treatment group; thus,
there was no blinding to group or treatment of the principal
investigator. Once the randomization process was completed,
anthropometric measures, strength, ROM, accessory
movement and stability testing of the foot was performed.
Subjects in group one received only ECSWT. Treatment
consisted of 2000 shockwaves at an intensity of 2.5 bars,
10-15 Hz and 11.5 Mp using a D Actor 100 Radial
Shockwave Unit developed by Storz Medical[8]. The
applicator was positioned over the painful site and plantar
fascia. Subjects received three treatments in total spaced one
week apart over a three week period.
Subjects in group two received ECSWT as described
previously and joint mobilizations. Mobilizations included
posterior glides of the talus on the tibia to increase talocrural
dorsiflexion, lateral glides of the calcaneous on the talus at
the posterior subtalar to increase supination, and dorsal
glides of the first proximal phalanx on the first metatarsal to
increase MTP extension of the first ray. Mobilizations
consisted of three sets of grade II and three sets of III
oscillations as described by Maitland, performed for 30
seconds[24]. These mobilizations were chosen as over
pronation, decreased ankle dorsiflexion and decreased first
MTP joint ROM have been described as contributing risk
factors for PF[7, 10, 11, 27, 29, 44, 48, 53, 56]. The goal of
these mobilization techniques was to increase ROM, thereby,
reducing stress on the plantar fascia. Each subject received
three treatments in total spaced one week apart over a three
week period of time and included both ECSWT and
mobilizations. Subjects in group two were not prescribed any
therapeutic exercises (stretching or strengthening).
Subjects in group three received ECSWT as described
previously and stretching exercises for the gastrocnemius,
soleus and plantar fascia, and ankle strengthening. Calf
muscle and plantar fascial stretches were held for 30 seconds
with three repetitions performed three times per day[31, 47].
Three sets of ten repetitions of strengthening exercises for
the ankle with theraband and towel exercises for the intrinsic
foot muscles were performed three times per day. Exercise
parameters including frequency, repetitions and sets were

based upon Rhea et al[42] and the American College of
Sports Medicine guidelines[1,2]. These stretches were
chosen as decreased dorsiflexion has been identified as a
possible cause of PF[7, 11, 27, 29, 56]. When these
stretching exercises have been used, good relief in heel pain
has been reported[18, 31, 39, 40, 47, 49]. Longer term relief
has been reported in patients that were also treated with
plantar fascial stretching[13, 16, 52]. As a result, the
combination of these exercises were used. Subjects received
three treatments in total spaced one week apart over a three
week period of time. During each treatment subjects
received ECSWT. The exercises were performed
independently at home but the exercise details were
reviewed each week at the treatment session to formally
check and review compliance with the exercise and
encourage the participants to complete the program
appropriately. No other form of exercise compliance was
monitored and no level of non-compliance was established to
disqualify participants from the study (figure 1).
85 patients diagnosed with PF and screened
for inclusion criteria

Excluded n=10
3 did not meet criteria
7 did not consent to participate

Randomized n=75

Group 1, n=25

Group 2, n=25

Group 3, n=25

Assessed, baseline VAS and LEFS

Group 1
ECSWT
3 treatments of
ECSWT (spaced
1 week apart)
over 3 week
period of time

Group 2
ECSWT and
ankle and foot
mobilizations
3 treatments of
ECSWT and
joint mobilization
(spaced 1 week
apart) over 3 week
period of time

Group 3
ECSWT
and exercise
3 treatments of
ECSWT and
exercise (spaced
1 week apart)
over 3 week
period of time

3 months follow up VAS and LEFS
Group 1, n=25
Group 2, n=25
Group 3, n=25
Figure 1. Study design flowchart

All subjects were treated individually by the principal
investigator, a physiotherapist with 20 years of clinical
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experience and a Fellow of the Canadian Academy of
Manual Physiotherapists. Subjects had no contact or
knowledge of the identity of any other participants. Each
session lasted approximately 30-60 minutes. All baseline and
follow-up measurements and treatment sessions were carried
out by the principal investigator. All subjects were also
instructed to avoid NSAIDS or aspirin products for the
duration of the study.
Pre-test measures for the LEFS and VAS were taken prior
to the initial assessment. These variables were also
reassessed during each individual treatment session and then
reassessed at three months post-treatment. For analysis, only
the pre and 3 months post measures were used. All subjects
participated in each treatment and testing session and no
adverse events or dropouts occurred in the study.
2.4. Sample-Size Calculation
The sample-size calculation for analysis of variance
(dfb=2) for VAS score utilized a change of 30 mm as the
minimal clinically significant difference (MCSD) on a 100
mm scale. A study by Williamson and Hoggart[57] found
that repeat measures with the VAS could vary by 20%. Thus,
with the significance level set at .05, a standard deviation
(SD) of 20 mm was used to achieve a power level of 85% for
an estimated 21 subjects per group.
The sample-size calculation for a 2-tailed test for VAS
score utilized a change of 30 mm as the minimal clinically
significant difference (MCSD) on a 100 mm scale with a
standard deviation (SD) of 20 mm. To achieve a power level
of 90% with the significance level set at .05, 25 subjects per
group were needed.
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ECSWT and joint mobilizations (n=25), and ECSWT and
exercise (n=25). Descriptive data for height, weight, and
BMI is summarized in Table 1. All groups improved over
time in all VAS scores and in the LEFS (Table 2).
The baseline score was subtracted from the final score to
obtain a change value for each appropriate dependent
variable. A One-way ANOVA was run to determine if there
was a statistically significant difference in the pain levels
between treatment groups for the LEFS score and VAS of
pain at rest, with activity, and pain improvement (see Figures
2-5). There was a statistically significant difference between
groups for pain levels with activity (F (2, 72)= 3.577,
p= .033). Effect size was calculated using Cohen’s d =.655
which demonstrated a large effect size, yielding a 99%
power. The Tukey post hoc test identified a difference
between the ECSWT and mobilization and ECSWT and
exercise group. The mean VAS score for pain after activity
was significantly lower for ECSWT and mobilization
compared to ECSWT and exercise (Table 2). No other
statistical significance was found between groups for any of
the other dependent variables.

2.5. Statistical Analysis
SPSS Version 20.0 (SPSS Inc., Chicago, IL) was utilized
to analyze means, SD and 95% confidence interval (CI) for
the descriptive characteristics of the cohort and for pre and
post changes within and between treatment groups. The
Kolmogorov-Smirnov test for normality was used and was
not significant revealing a normal distribution of the data. A
One-way ANOVA was used to determine if there was a
difference between treatment groups for the VAS and LEFS.
If significance was found a Tukey post-hoc test was used to
identify where the difference lies. Cohen’s d was used to
calculate effect size with .8 being large, .5 medium, and .2
small. A dependent T-test was used to determine if there was
a significant change from pre to post scores for the VAS and
LEFS scores within each group. For all analyses the alpha
level was set at .05.

3. Results
The sample consisted of 75 subjects (22 males and 53
females) with a mean age of 47 years with each subject
randomized into one of three groups, ECSWT (n=25),

LEFS scores by treatment group pre-treatment and
Figure 2.
post-treatment (mean pre and post LEFS scores contained in text box within
columns; pre-treatment LEFS score
; post-treatment LEFS score
;)
Table 1. Demographic Information for all Subjects

Age (years)

48 ± 10.9

ECSWT and
Joint Mobs
47 ± 6.0

Gender

9 M, 16 FM

8 M, 17 FM

5 M, 20 FM

Height (inches)

65.8 ± 4.5

67.0 ± 4.4

66.1 ± 3.1

Weight (pounds)

192.8 ± 26.2

187.2 ± 24.0

190.5 ± 22.8

BMI (kg/meter2)

31.3

29.3

30.7

Treatment Group

ECSWT

ECSWT and
Exercise
48 ± 8.8

Abbreviations: BMI, Body Mass Index; M,male;FM,female.
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Table 2. Group Outcome Data for Pain (VAS) and Function (LEFS)
VAS At Rest
Pre-treatment
Post-treatment
Within group change score
Within
Between
VAS After Activity
Pre-treatment
Post-treatment
Within group change score
Within
Between
VAS Overall Improvement
Pre-Treatment
Post-Treatment
Within
Between
LEFS (0-100)
Pre-Treatment
Post-Treatment
Within group change score
Within
Between

ECSWT (n=25)

ECSWT and Jt Mobs (n=25)

ECSWT and Exer (n=25)

34.8 ± 29.0
18.2 ± 24.4
16.56 (7.6, 25.6)
b
T= 3.79, P= .001
F= .147, P=.863

29.4 ± 33.6
9.5 ± 12.9
19.76 (9.0, 30.5)
b
T=3.84, P= .001

45.8 ± 29.4
25.0 ± 27.4
20.68 (6.2, 35.1)
b
T=2.97, P=.007

79.6 ± 13.5
31.5 ± 23.2
48.0 (39.3, 56.7)
b
T = 11.39, P < .001
a
F=3.57, P=.033

78.7 ± 6.8
25.64 ± 22.7
a
51.7 (40.9, 62.5)
b
T=11.46, P < .001

73.6 ± 18.5
42.4 ± 34.0
a
33.0 (20.3, 45.6)
b
T=4.81, P < .001

.00 ± .00
63.4 ± 23.5
b
T= -13.46, P < .001
F=2.81, P=.067

.00 ± .00
72.3 ± 30.7
b
T= -11.76, P< .001

.00 ± .00
52.2 ± 34.8
b
T=-7.48, P < .001

46.9 ± 12.3
61.1 ± 14.9
13.6 (7.3, 20.0)
b
T= -4.76, P < .001
F=.643, P=.529

46.5 ± 15.0
64.7 ± 16.5
18.7 (12.26, 25.1)
b
T= -5.75, P < .001

40.4 ± 16.6
54.9 ± 20.0
14.5 (6.64, 22.4)
b
T=-3.80, P= .001

Abbreviations: VAS, Visual Analog Scale; LEFS, Lower Extremity Function Scale; ECSWT, Extracorporeal Shock Wave Therapy; Jt Mobs, joint
mobilization; Exer, Exercise.
a
One-Way ANOVA Significant at P ≤ .05.
b
Independent T-test significant at P ≤ .05. Upper and lower bound means in parentheses at 95% confidence interval.

Figure 3. VAS scores for heel pain at rest by treatment group
pre-treatment and post-treatment (mean pre and post VAS scores contained
in text box within columns; pre-treatment VAS score
; post-treatment
VAS score
;)

Figure 4. VAS scores for heel pain following activity by treatment group
pre-treatment and post-treatment (mean pre and post VAS scores contained
in text box within columns; pre-treatment VAS score
; post-treatment
VAS score
;
significant between groups P<.05)
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Figure 5. VAS scores for overall improvement in heel pain by treatment
group pre-treatment and post-treatment (mean pre and post VAS scores
contained in text box within columns; pre-treatment VAS score
;
post-treatment VAS score
;)

4. Discussion
It was hypothesized that ECSWT in combination with
mobilization and exercise would have a greater effect on heel
pain and function compared to ECSWT alone. All three
groups had a clinically significant change in the VAS score
for pain after activity, but the combination of ECSWT and
joint mobilizations resulted in a statistically (p=.033) and
clinically significant improvement when compared to the
combination of ECSWT and exercise. This finding
demonstrated a large effect size (d=.7) suggesting that there
is a strong relationship between this treatment and the
resulting reduction in pain. Joint mobilizations of the
talocrural, subtalar, and first MTP joints when combined
with ECSWT may be an effective treatment option in
improving heel pain. Furthermore, all three groups improved
in function as measured by the LEFS. Although this
improvement was not statistically significant, each group
demonstrated a clinically significant change in LEFS scores
(post-treatment score changed by more than 9 points).
Although not statistically significant, the greatest
improvement in VAS and LEFS scores was consistently
found in the ECSWT and joint mobilizations group. Subjects
that were randomly allocated to this treatment group all
received joint mobilizations whether or not it was necessary
and joint stiffness was present. In the clinical setting, the
healthcare provider would assess the patient and conclude
whether joint mobilizations are appropriate. This would be
based upon the assessment and clinical reasoning findings,
and the healthcare provider’s determination that joint
mobilizations were indicated. Therefore, the healthcare
provider that is using ECSWT for the treatment of the PF
patient should consider combining this with joint
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mobilizations to the talocrural, subtalar, and first MTP joints
especially if ROM and accessory glide restrictions are noted
during the assessment. This may, in turn, produce the most
effective and greatest reduction in the patient’s heel pain.
It should be highlighted that the inferences made above
from the results of this study are limited by the fact that a
control group was not used. The initial intent of this study,
however, was to assess whether the use of ECSWT used in
isolation would have the same effects as if ECSWT was
combined with joint mobilizations or exercise. Based on the
current results the consistent trends described above
definitely suggests some positive findings and warrants
further study examining the combinations of treatment using
a different study design and control group.
Studies examining the effects of mobilizations alone or
compared to ECSWT are very limited. Cleland et al[9]
reported that mobilizations directed to the hip, knee, and
ankle combined with exercises were superior to the use of
therapeutic modalities and exercise in improving heel pain
and function in patients with PF. Cleland et al[9] used similar
joint mobilizations to the talocrural and subtalar joints but
did not include mobilizations of the first MTP joint. They
mobilized several other joints including the hip, knee,
inferior tibiofibular, and calcaneocuboid joints and also
performed several soft tissue techniques. The different
manual therapy techniques used by Cleland et al[9] varied
from subject to subject with the treating practitioner using an
impairments based manual therapy approach deciding what
treatment to use based upon the assessment findings. Each
subject in the mobilization and exercise group did not
receive the same treatment technique making it difficult to
conclude what produced the treatment effect. Future studies
looking at ECSWT in combination with other interventions
such as exercise or joint mobilizations should incorporate
this impairment based treatment progression. This would
allow the healthcare provider to use clinical reasoning to
progress or modify the treatment regime according to the
patient’s clinical presentation.
It is possible that in the current study the combination of
ECSWT and joint mobilizations to the talocrural, subtalar,
and first MTP joints may have increased the joint mobility,
improved the efficiency of the windlass mechanism, or had a
segmental anti-nociceptive effect via stimulation of local
mechanoreceptors thereby reducing strain on the plantar
fascia. These treatments may have also improved the blood
flow to the region, increased the elasticity of the tissue and
stimulated connective tissue remodeling[21, 22, 24, 32, 37,
41, 46]. These hypotheses may explain some of the benefits
noted in our study with this combination of treatments but
due to the current study design and the lack of a control
group we must make this conclusion cautiously.
Overall, the ECSWT treatment group and the ECSWT and
exercise treatment group improved similarly suggesting that
the addition of exercise was not consequential. A possible
reason for this may have been due to a lack of compliance by
subjects with the prescribed exercise program, or due to the
actual exercises that were used as part of the intervention.
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The therapeutic benefits, optimal exercise, intensity, speed,
load and frequency of any stretching or strengthening
program used in patients with PF is unclear, and there is no
explicit explanation as to why or why not exercise may or
may not help. The lack of improvement with exercise
combined with ECSWT may also have been due to the lack
of treatment and the possibility that three treatment sessions
were not sufficient. Rompe et al[45] compared the effects of
ECSWT to exercise and reported a greater improvement in
acute heel pain with plantar fascial stretching compared to
ECSWT. Rompe et al[44] also reported improved function
and greater overall satisfaction in another study in patients
who received therapeutic exercises compared to ECSWT.
The contrasting findings from the current study may be
attributed to the slightly different stretching parameters used
(type of exercise and dosage). The stretches used by Rompe
et al[44, 45] consisted of a static self-manual stretch to the
plantar fascia completed in a sitting position compared to
stretches for the gastrocnemius and soleus muscles and the
plantar fascia completed in standing used in the current study.
The use of the combination of stretching exercises for the
plantar fascia and calf muscles in our study is consistent with
what has been described in several previous studies[16, 19,
22, 45, 54]. The length of time that the stretch was held also
differed and was longer in our study (30 second holds, for
three repetitions and repeated three times per day compared
to 10 second holds, for 10 repetitions and repeated twice per
day). The exercise program also differed in our study
because the stretching exercises were also combined with
strengthening exercises and this may have somehow
impacted on the results.
Other possible factors that may have influenced the results
of this study is the treatment process. The ECSWT and joint
mobilization group had the most direct hands on care.
Rompe et al[44] raised this question in his study and whether
the improved satisfaction of patients was related to the
outcome of treatment or the process in which the treatment
was carried out. The process of treatment can be described as
the type and way in which the treatment is performed. The
outcome of treatment can be described as the effectiveness of
the intervention and the post-treatment effect. The greater
improvement noted in our study with ECSWT and
mobilizations may have been influenced by the process of
treatment. With regards to the joint mobilizations, the patient
may have reported benefit and positive feedback because of
the touch and tactile stimulation used by the treating
physiotherapist and the effect on the mechanoreceptors in the
region.
Lastly, while all groups improved from pre to post
treatment, neither group achieved complete pain relief or
restoration of function at three months post-treatment. This
may be due to the fact that insufficient treatment was
provided. Three treatments of ECSWT, manual therapy, or
exercise may not have been sufficient and patients may have
continued to improve if more treatment was provided. The
frequency of ECSWT treatment in our study is consistent

with the number of treatments proposed and used in most
treatment protocols.
Several studies have highlighted the long term benefit of
ECSWT in the treatment of plantar heel pain. Our results are
similar to these studies with the overall improvement at the
three month follow up ranging from 52-72%. Gerdesmeyer
et al[20] reported a significant improvement in VAS pain
scores and functional scale scores at 4 months and 12 months
follow up when compared to placebo. Two hundred and forty
five subjects with chronic PF were randomly assigned either
into the ECSWT treatment group or the placebo treatment
group. The ECSWT treatment group received three
treatments of 2000 shockwaves applied to the painful heel
spaced two weeks apart. The placebo treatment group
received ECSWT using the same parameters described but a
placebo hand piece was used that prevented the actual
transmission of the shockwaves. The overall success rates
ranged from 61% in the ECSWT group as compared to
42.2% in the control group. Similarly, we found a 63%
improvement in our study for the ECSWT group when using
the same number of shockwaves but spacing the treatment
apart by one week. Chuckpaiwong et al[7] also reported
similar success rates to those of the current study. At the
three month follow up, they found a 70.7% reduction and at
12 months a 77.2% improvement in VAS scores for pain
with the first few steps in the morning, pain during daily
activities and exercise, and an in functional scale outcome
scores.
Although different treatment parameters and different
ECSWT generators have been used in the studies highlighted,
the long term benefit and success rates of ECSWT appear to
be consistent with the findings of our study. In several of the
studies highlighted, despite the use of different ECSWT
treatment parameters most patients improved over time.
Some variability in the amount of improvement, however,
has been reported in the literature regarding the success of
ECSWT in patients with PF. This once again supports the
use of this intervention in the treatment of heel pain but also
reinforces the need for further research.
As mentioned previously, a limitation to this study was the
lack of a true control group. In order to determine the
influence of ECSWT on the outcomes in this study, a group
that received only joint mobilizations or exercise was needed.
Future study designs that examine the effects of
combinations of treatment with ECSWT must include
appropriate controls in which the alternate intervention is
used in isolation. Another limitation of the current study was
the number of treatments used for the exercise group and not
including a method for encouraging or monitoring
compliance with exercise. Future studies should incorporate
greater treatment frequency, a method of monitoring patient
compliance, and a cut off whereby patients will not be
included in the statistical analysis if a certain degree of
compliance is not obtained. Finally, the number of
treatments for the joint mobilization group and an
impairments based progression should be implemented so
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that only patients that require joint mobilizations receive this
treatment in future studies.

5. Conclusions
All patients experienced improvements in function and
heel pain with the use of ECSWT alone or in combination
with joint mobilization or exercise. It appears that this
modality has positive effects in the treatment of pain and
function. The combination of ECSWT with joint
mobilizations appears to be more effective than the
combination of ECSWT with stretching and strengthening
exercises to improve heel pain following activity. Treating
practitioners may want to consider this treatment
combination if the primary aggravating factor for heel pain is
activity or post exercise. Further research is required that
integrate the examination of combinations of treatments with
ECSWT as this modality continues to be used more
frequently clinically. Most healthcare providers do not treat
solely with one modality or treatment approach so more
research is required such as this study that examines
combinations of treatments to simulate the actual clinical
combinations used in the practical settings. Future studies
must incorporate alternate designs to control for the
limitations described in the current study.
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